Kura Oncology, Inc. (KURA) is a publicly traded Healthcare sector company. As of May 21, 2026, KURA trades at $10.60 with a market cap of $816.72M and a P/E ratio of -3.19. KURA moved +15.29% today. Year to date, KURA is +8.39%; over the trailing twelve months it is +62.07%. Its 52-week range spans $5.41 to $19.94. Analyst consensus is strong buy with an average price target of $28.13. Rallies surfaces KURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kura Oncology, Inc. (KURA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KURA moved +15.29% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $10.60 |
| Market Cap | $816.72M |
| P/E Ratio | -3.19 |
| EPS | $-3.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.94 |
| 52-Week Low | $5.41 |
| Volume | 4.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $67.48M |
| Net Income | $-278.67M |
| Gross Margin | 0.00% |
10 analysts cover KURA: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.13.